Balyasny Asset Management LLC Moon Lake Immunotherapeutics Transaction History

Balyasny Asset Management LLC

$72.4 Billion
Q3 2025

A detailed history of Balyasny Asset Management LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Balyasny Asset Management LLC holds 29,700 shares of MLTX stock, worth $379,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,700

Previous 423,170 92.98%

Holding current value

$379,269

Previous $20 Million 98.94%

% of portfolio

0.0%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$6.25 - $61.99 $7.98 Million - $79.1 Million	1,276,065 Added 301.55%	1,699,235 $12.2 Million
Q2 2025 Aug 14, 2025	BUY	$32.84 - $51.05 $11.3 Million - $17.6 Million	344,335 Added 436.78%	423,170 $20 Million
Q1 2025 May 15, 2025	SELL	$36.75 - $54.34 $4.69 Million - $6.94 Million	-127,733 Reduced 61.84%	78,835 $3.08 Million
Q4 2024 Feb 14, 2025	SELL	$45.84 - $57.91 $7.04 Million - $8.9 Million	-153,632 Reduced 42.65%	206,568 $11 Million
Q3 2024 Nov 14, 2024	SELL	$40.15 - $55.4 $9 Million - $12.4 Million	-224,063 Reduced 38.35%	360,200 $18.2 Million

Q2 2024 Aug 14, 2024	BUY	$38.43 - $48.6 $6.13 Million - $7.76 Million	159,568 Added 37.57%	584,263 $25.7 Million
Q1 2024 May 13, 2024	SELL	$43.78 - $63.86 $7.61 Million - $11.1 Million	-173,815 Reduced 29.04%	424,695 $21.3 Million
Q4 2023 Feb 14, 2024	BUY	$36.35 - $63.02 $13.2 Million - $23 Million	364,260 Added 155.5%	598,510 $36.1 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $7.97 Million - $10.1 Million	164,909 Added 237.82%	234,250 $13.4 Million
Q2 2023 Aug 14, 2023	SELL	$19.01 - $51.79 $2.44 Million - $6.65 Million	-128,366 Reduced 64.93%	69,341 $3.54 Million
Q1 2023 May 15, 2023	SELL	$11.03 - $23.7 $223,820 - $480,920	-20,292 Reduced 9.31%	197,707 $4.23 Million
Q4 2022 Feb 14, 2023	BUY	$7.05 - $10.5 $832,781 - $1.24 Million	118,125 Added 118.27%	217,999 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$5.25 - $9.27 $524,338 - $925,831	99,874 New	99,874 $795,000

Others Institutions Holding MLTX

# of Institutions

181

Shares Held

38.5M

Call Options Held

4.13M

Put Options Held

1.54M

View Full List

About MoonLake Immunotherapeutics

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $472M
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

More about MLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Moon Lake Immunotherapeutics Transaction History